FDA Advisory Committee Will Soon Meet to Discuss MDMA-Assisted Therapy for PTSD

10 months ago

As reported in Drug Topics The Psychopharmacologic Drugs Advisory Committee will meet June 4 to review a new drug application from Lykos Therapeutics. The FDA’s Psychopharmacologic Drugs Advisory Committee will meet on June 4 to review a new drug application (NDA) from Lykos Therapeutics for midomafetamine (MDMA)-assisted therapy to treat post-traumatic stress disorder (PTSD).1 What’s […]